Offered by: Nemours Children's
Location: Orlando, Fla.
A Multinational Trial Evaluating Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Patients With Hemophilia A
Study of children with severe hemophilia A.
Male patients at least 12 years old.
Participation in this study will last about 6 months in the on-demand arm and about 7 to 19 months in the prophylaxis arm. There will be a total of up to 12 study visits each lasting no more than 2 hours each. Complete physical exam, and blood/urine samples.
Trial Name: A Multinational Trial Evaluating Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Patients with Hemophilia A
IRB#: 308004
Learn more about clinical trials and get answers to questions you might have.
Go to FAQs View All Clinical TrialsNemours has a number of service regions. Selecting your region will help us show you the right contact information and the most relevant content for you.